SCHEMBL7187650

SCHEMBL7187650

CCOc1c(C=CC(=O)c2ccc(N)cc2)cc(C(C)(C)CC)c(O)c1C(C)(C)CC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
PTPN1 P18031 1/20 0.41
CYP1A1 P04798 3/20 0.40
CYP1B1 Q16678 3/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
KRAS P01116 1/20 0.40
PTGS1 P23219 1/20 0.39
DPP4 P27487 2/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ATM Q13315 1/20 0.39
MAOB P27338 2/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
BCHE P06276 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7187646 1.00 CTSL (0.43) CTSLCTSBPTPN1CYP1A1CYP1B1
SCHEMBL7192357 0.92 CTSL (0.42) CTSLCTSBPTPN1CYP1A1CYP1B1
SCHEMBL7192360 0.92 CTSL (0.42) CTSLCTSBPTPN1CYP1A1CYP1B1
SCHEMBL7186737 0.92 ABCG2 (0.47) CTSLCTSBPTPN1CYP1A1CYP1B1
SCHEMBL7186733 0.92 ABCG2 (0.47) CTSLCTSBPTPN1CYP1A1CYP1B1
SCHEMBL7186692 0.91 CTSL (0.49) CTSLCTSBPTPN1CA1CA2
SCHEMBL7186696 0.91 CTSL (0.49) CTSLCTSBPTPN1CA1CA2
SCHEMBL7186242 0.88 CYP1A1 (0.39) PTPN1CYP1A1CYP1B1PTGS1DPP4
SCHEMBL7190816 0.88 CTSL (0.42) CTSLCTSBPTPN1CYP1B1CA1
SCHEMBL7186244 0.88 CYP1A1 (0.39) PTPN1CYP1A1CYP1B1PTGS1DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed